NTMT-03-B A Phase III Multicenter Randomized, Sham Controlled, Study to Determine the Safety and Efficacy of Renexus® in Macular Telangiectasia type 2.

Project: Research project

Project Details

StatusFinished
Effective start/end date7/3/18 → 12/31/22

Funding

  • Lowy Medical Research Institute Limited (NTMT03-B)